cytokine induced killer cells Report issue

Cell therapy Experimental
AACT

Active Ingredient History

NOW
  • Now
In cell biology, a lymphokine-activated killer cell is a white blood cell that has been stimulated to kill tumor cells. If lymphocytes are cultured in the presence of Interleukin 2, it results in the development of effector cells which are cytotoxic to tumor cells.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

cytokine-induced killer cell | cytokine induced killer cells | cytokine-induced killer cells | lymphokine-activated killer cells

Organizations (52)

Research & Development (52)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (41)

Approved Indications (1)


 

Neoplasms

Experimental Indications - Clinical Trial Phases 1-4 (41)


 

Adenocarcinoma of Lung (Phase 2)

Anemia (Phase 2)

Bone Marrow Cells (Phase 1)

Bone Marrow Transplantation (Phase 2)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 1/Phase 2)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2/Phase 3)

Carcinoma, Renal Cell (Phase 1/Phase 2)

Carcinoma, Squamous Cell (Phase 2/Phase 3)

Cholangiocarcinoma (Phase 2/Phase 3)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 4)

Cytokine-Induced Killer Cells (Phase 4)

Esophageal Neoplasms (Phase 1/Phase 2)

Esophageal Squamous Cell Carcinoma (Phase 2)

Glioma (Phase 4)

Hematologic Neoplasms (Phase 2)

Kidney Neoplasms (Phase 1/Phase 2)

Leukemia (Phase 1)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 1/Phase 2)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 1/Phase 2)

Lymphoma, B-Cell (Phase 1/Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Melanoma (Phase 2)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Nasopharyngeal Carcinoma (Phase 1/Phase 2)

Neoplasms (Phase 2)

Neural Tube Defects (Phase 2)

Ovarian Neoplasms (Phase 2)

Postoperative Complications (Phase 4)

Sarcoma (Phase 1/Phase 2)

Small Cell Lung Carcinoma (Phase 1/Phase 2)

Stomach Neoplasms (Phase 2)

Survival (Phase 4)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 54
  • # of Trial Organizations: 52

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue